Apelin‑13 in the paraventricular nucleus (PVN) attenuates myocardial ischemia through V1a receptors in PVN/nucleus tractus solitarii (NTS) and GARγ2 in NTS.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Apelin‑13 in the paraventricular nucleus (PVN) attenuates myocardial ischemia through V1a receptors in PVN/nucleus tractus solitarii (NTS) and GARγ2 in NTS.
- Published In:
- International journal of molecular medicine, 56(6) (2025)
- Authors:
- Yan, Wen, Wang, Dan, Zhang, Xinmin, Xuan, Chengluan
- Database ID:
- RPEP-14318
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-14318APA
Yan, Wen; Wang, Dan; Zhang, Xinmin; Xuan, Chengluan. (2025). Apelin‑13 in the paraventricular nucleus (PVN) attenuates myocardial ischemia through V1a receptors in PVN/nucleus tractus solitarii (NTS) and GARγ2 in NTS.. International journal of molecular medicine, 56(6). https://doi.org/10.3892/ijmm.2025.5652
MLA
Yan, Wen, et al. "Apelin‑13 in the paraventricular nucleus (PVN) attenuates myocardial ischemia through V1a receptors in PVN/nucleus tractus solitarii (NTS) and GARγ2 in NTS.." International journal of molecular medicine, 2025. https://doi.org/10.3892/ijmm.2025.5652
RethinkPeptides
RethinkPeptides Research Database. "Apelin‑13 in the paraventricular nucleus (PVN) attenuates my..." RPEP-14318. Retrieved from https://rethinkpeptides.com/research/yan-2025-apelin13-in-the-paraventricular
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.